P
LLY icon

&Partners’s Eli Lilly LLY Stock Holding History

&Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$158M Buy
171,696
+11,110
+7% +$11.3M 0.78% 19
2025
Q4 		$173M Buy
160,586
+37,368
+30% +$35.7M 0.9% 15
2025
Q3 		$94M Buy
123,218
+3,918
+3% +$2.92M 0.6% 22
2025
Q2 		$93.1M Buy
119,300
+26,762
+29% +$20.8M 0.71% 19
2025
Q1 		$76.2M Buy
92,538
+25,466
+38% +$21.2M 0.81% 16
2024
Q4 		$52.7M Buy
67,072
+27,755
+71% +$23M 0.63% 24
2024
Q3 		$34.8M Buy
39,317
+22,632
+136% +$20.3M 0.67% 16
2024
Q2 		$15.1M Buy
16,685
+14,305
+601% +$11.4M 0.66% 22
2024
Q1 		$1.86M Sell
2,380
-2,602
-52% -$1.85M 0.26% 78
2023
Q4 		$2.92M Buy
4,982
+3,944
+380% +$2.3M 0.71% 29
2023
Q3 		$558K Buy
1,038
+227
+28% +$117K 0.26% 74
2023
Q2 		$380K Buy
811
+135
+20% +$56.6K 0.17% 106
2023
Q1 		$232K Buy
676
+3
+0.4% +$1.01K 0.11% 145
2022
Q4 		$246K Sell
673
-318
-32% -$113K 0.12% 144
2022
Q3 		$320K Buy
991
+90
+10% +$28.5K 0.19% 112
2022
Q2 		$292K Buy
+901
New +$270K 0.17% 123

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

&Partners's LLY Position: Q1 2026 in Review

&Partners increased its Eli Lilly (LLY) stake by 6.9% in Q1 2026, buying an estimated $11.3M and bringing the position to 171,696 shares worth $158M. The position accounts for 0.78% of the portfolio, ranked #19.

&Partners first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $173M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • &Partners held 171,696 shares of Eli Lilly worth $158M as of Q1 2026.
  • &Partners bought 11,110 Eli Lilly shares in Q1 2026, an estimated $11.3M.
  • Eli Lilly made up 0.78% of &Partners's portfolio in Q1 2026, its #19 holding.
  • &Partners first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • &Partners's Eli Lilly position peaked at $173M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.